The global clot management devices market accounted for USD 1.82 billion in 2023 and is expected to reach at USD 3.14 billion by 2034 with a CAGR of 5.08% during the forecast period 2024-2034. Rising need for efficient thrombectomy/embolectomy devices, increased recognition of modern clot management techniques, growing prevalence of cardiovascular diseases, surge in aging population, rising demand for advanced medical technology, a significant mortality rate prompting the development of technologically advanced clot management devices, surge in demand for minimally invasive procedures, and increasing introduction of new clot management devices are some of the key factors boosting the market growth.
Increasing introduction of new clot management devices is predicted to boost the market growth during the forecast period. Clot management devices serve as medical tools employed to treat and prevent blood clots, which pose significant health risks. These devices are designed to target blood clots within arteries or veins, thereby reducing the chances of heart attacks, strokes, or deep vein thrombosis. For instance, in January 2023, Penumbra, Inc. has launched Lightning Flash, a state-of-the-art mechanical thrombectomy system featuring dual clot detection algorithms, after receiving FDA clearance. This development positions it as the most potent and groundbreaking device available in the market.
By product, percutaneous thrombectomy devices was the highest revenue-grossing segment in the global clot management devices market in 2023 owing to its unique benefits compared to conventional invasive techniques, escalating occurrence of Deep Vein Thrombosis (DVT) & arterial thrombosis, rising need for minimally invasive procedures, and increasing effectiveness of percutaneous medical devices. Additionally, embolectomy balloon catheter is predicted to grow at the fastest CAGR during the forecast period owing to the growing prevalence of coronary artery diseases & other cardiovascular diseases (CVDs), continuous innovation of products by leading industry players, and increasing number of product launches. For instance, in February 2022, Vena Medical has obtained the inaugural medical device license from Health Canada for its latest offering, the Vena balloon distal access catheter. This device merges the functionalities of balloon guide catheters and distal access catheters, which are presently utilized in thrombectomy procedures aimed at extracting clots from the brains of stroke sufferers.
By end-user, hospitals was the highest revenue-grossing segment in the global clot management devices market in 2023 as the hospitals are the main point of care for patients with conditions such as Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE), are endorsing & employing these devices, heightened demand for cardiovascular treatments, increase in collaborations among industry participants, emergence of telestroke services, and enhanced reimbursement rates. Additionally, diagnostic centers is predicted to grow at the fastest CAGR during the forecast period owing to its essential function in facilitating clot management procedures is emphasized, increasing use of advanced imaging technologies such as ultrasound & CTPA scans, rise in the incorporation of artificial intelligence (AI) in diagnostic centers, and ongoing technological advancements. For instance, in April 2022, Penumbra, Inc., an international healthcare firm specializing in groundbreaking treatments, unveiled its Indigo Aspiration System featuring Lightning 7 and Lightning 12. This system is engineered for the removal of blood clots in peripheral arteries and veins in a single session, catering to conditions such as pulmonary embolisms. With the acquisition of the CE Mark, the product is now accessible for commercial use in Europe.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing incidence of high blood pressure & cholesterol levels among adults, growing elderly population, rise in the prevalence of these conditions, and surge in the introduction of new products. For instance, in February 2022, A groundbreaking development in stroke therapy has been made possible by Imperative Care, Inc.'s introduction of their Zoom POD Aspiration Tubing. This product stands as the sole filter capable of capturing clots within the sterile field. The Zoom POD joins Imperative Care's Zoom Stroke Solution, which encompasses a range of ischemic stroke treatment options, including the Zoom 88 Large Distal Platform for neurovascular access, four Zoom Aspiration Catheters available in different sizes, and the Zoom Pump along with its accompanying accessories. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the occurrence of cardiovascular diseases, increased demand for cardiology medical devices used in both diagnosis & treatment, growing need for advanced technologies, and surge in the introduction of innovative solutions. For instance, in April 2022, Medtronic has initiated a registry to gather real-world data related to the use of revascularization devices in acute ischemic stroke (AIS) patients. Known as the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neurothrombectomy Devices in India (PRAAN), this pioneering effort in the industry aims to establish a post-market registry to evaluate the clinical outcomes linked with the utilization of Medtronic's revascularization devices in individuals undergoing acute ischemic stroke.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increasing introduction of new clot management devices is predicted to boost the market growth during the forecast period. Clot management devices serve as medical tools employed to treat and prevent blood clots, which pose significant health risks. These devices are designed to target blood clots within arteries or veins, thereby reducing the chances of heart attacks, strokes, or deep vein thrombosis. For instance, in January 2023, Penumbra, Inc. has launched Lightning Flash, a state-of-the-art mechanical thrombectomy system featuring dual clot detection algorithms, after receiving FDA clearance. This development positions it as the most potent and groundbreaking device available in the market.
By product, percutaneous thrombectomy devices was the highest revenue-grossing segment in the global clot management devices market in 2023 owing to its unique benefits compared to conventional invasive techniques, escalating occurrence of Deep Vein Thrombosis (DVT) & arterial thrombosis, rising need for minimally invasive procedures, and increasing effectiveness of percutaneous medical devices. Additionally, embolectomy balloon catheter is predicted to grow at the fastest CAGR during the forecast period owing to the growing prevalence of coronary artery diseases & other cardiovascular diseases (CVDs), continuous innovation of products by leading industry players, and increasing number of product launches. For instance, in February 2022, Vena Medical has obtained the inaugural medical device license from Health Canada for its latest offering, the Vena balloon distal access catheter. This device merges the functionalities of balloon guide catheters and distal access catheters, which are presently utilized in thrombectomy procedures aimed at extracting clots from the brains of stroke sufferers.
By end-user, hospitals was the highest revenue-grossing segment in the global clot management devices market in 2023 as the hospitals are the main point of care for patients with conditions such as Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE), are endorsing & employing these devices, heightened demand for cardiovascular treatments, increase in collaborations among industry participants, emergence of telestroke services, and enhanced reimbursement rates. Additionally, diagnostic centers is predicted to grow at the fastest CAGR during the forecast period owing to its essential function in facilitating clot management procedures is emphasized, increasing use of advanced imaging technologies such as ultrasound & CTPA scans, rise in the incorporation of artificial intelligence (AI) in diagnostic centers, and ongoing technological advancements. For instance, in April 2022, Penumbra, Inc., an international healthcare firm specializing in groundbreaking treatments, unveiled its Indigo Aspiration System featuring Lightning 7 and Lightning 12. This system is engineered for the removal of blood clots in peripheral arteries and veins in a single session, catering to conditions such as pulmonary embolisms. With the acquisition of the CE Mark, the product is now accessible for commercial use in Europe.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing incidence of high blood pressure & cholesterol levels among adults, growing elderly population, rise in the prevalence of these conditions, and surge in the introduction of new products. For instance, in February 2022, A groundbreaking development in stroke therapy has been made possible by Imperative Care, Inc.'s introduction of their Zoom POD Aspiration Tubing. This product stands as the sole filter capable of capturing clots within the sterile field. The Zoom POD joins Imperative Care's Zoom Stroke Solution, which encompasses a range of ischemic stroke treatment options, including the Zoom 88 Large Distal Platform for neurovascular access, four Zoom Aspiration Catheters available in different sizes, and the Zoom Pump along with its accompanying accessories. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the occurrence of cardiovascular diseases, increased demand for cardiology medical devices used in both diagnosis & treatment, growing need for advanced technologies, and surge in the introduction of innovative solutions. For instance, in April 2022, Medtronic has initiated a registry to gather real-world data related to the use of revascularization devices in acute ischemic stroke (AIS) patients. Known as the Prospective Registry for Assessment of Acute Ischemic Stroke Patients Treated with Neurothrombectomy Devices in India (PRAAN), this pioneering effort in the industry aims to establish a post-market registry to evaluate the clinical outcomes linked with the utilization of Medtronic's revascularization devices in individuals undergoing acute ischemic stroke.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Product and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Clot Management Devices Market Report 2023 - 2034
Clot Management Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Embolectomy Balloon Catheters
- Neurovascular Embolectomy Devices
- Inferior vena cava filters (IVCF)
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis (CDT) devices
Clot Management Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Diagnostic Centers
Clot Management Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Clot Management Devices Market: Product Estimates & Trend Analysis
8. Clot Management Devices Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Clot Management Devices Market
11. Europe Global Clot Management Devices Market
12. Asia Pacific Global Clot Management Devices Market
13. Latin America Global Clot Management Devices Market
14. MEA Global Clot Management Devices Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- DePuy Synthes
- iVascular SLU
- Straub Medical AG
- Edwards Lifesciences Corporation
- Medtronic
- Vascular Solutions Inc
- Cook Medical
- LeMaitre Vascular Inc
- Teleflex Inc
